About 3.5 million patients worldwide depend on regular dialysis treatment. Fresenius Medical Care is committed to enabling a future worth living for these people. Our teams in Research and Development, operating in 23 locations across three regions, are responsible for the ongoing development of the medical products and treatments required across the renal care spectrum.
We drive research on innovative dialysis devices and turn it into reality. To deliver solutions that are continuously optimized and tailored to meet patients’ specific needs, we develop IoT-supported diagnostic methods and evidence-based, individualized treatments. Our integrated, multidisciplinary approach to research and development speaks to specialists as well as generalists.
As market leader, Fresenius Medical Care sets new, higher standards in dialysis. Help us define them: become part of a talented team that drives innovation in health care. Join our scientists and professionals in delivering excellence on a global scale.
As the world's leading provider of products and services for individuals with renal diseases, our numbers speak for themselves.
Data Science and Data Engineering
Software Engineering
UX/UI Design
Cybersecurity
Product Owner, Agile Coach and Scrum Master
Hardware Engineering
Electrical Engineering
Quality Engineering
Sustained Engineering
Clinical Research
Product Development
Program Project Management
Engineering Project Manager
Technical Writer
Our team operates in 23 locations across three regions: North America, EMEA (Europe, Middle East, and Africa) and Asia-Pacific.
“My job is to develop new membranes, cutting-edge technology that improves people’s lives,” says Dr. James Kennedy, Engineering Project Manager, Membrane and Filter Development. Discover what motivates us, every day, to push innovation forward.
Many patients suffering from Chronic Kidney Disease (CKD) in China and in other countries do not have access to dialysis treatment. In the China Design Center (CDC) of Fresenius Medical Care we are working to change this.